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Abstract
Previously we have demonstrated that a Rhodiola crenulata extract (RCE), containing a potent antioxidant salidroside,
promotes neurogenesis in the hippocampus of depressive rats. The current study was designed to further investigate the
protective effect of the RCE on neurogenesis in a rat model of Alzheimer’s disease (AD) induced by an
intracerebroventricular injection of streptozotocin (STZ), and to determine whether this neuroprotective effect is induced
by the antioxidative activity of salidroside. Our results showed that pretreatment with the RCE significantly improved the
impaired neurogenesis and simultaneously reduced the oxidative stress in the hippocampus of AD rats. In vitro studies
revealed that (1) exposure of neural stem cells (NSCs) from the hippocampus to STZ strikingly increased intracellular reactive
oxygen species (ROS) levels, induced cell death and perturbed cell proliferation and differentiation, (2) hydrogen peroxide
induced similar cellular activities as STZ, (3) pre-incubation of STZ-treated NSCs with catalase, an antioxidant, suppressed all
these cellular activities induced by STZ, and (4) likewise, pre-incubation of STZ-treated NSCs with salidroside, also an
antioxidant, suppressed all these activities as catalase: reduction of ROS levels and NSC death with simultaneous increases in
proliferation and differentiation. Our findings indicated that the RCE improved the impaired hippocampal neurogenesis in
the rat model of AD through protecting NSCs by its main ingredient salidroside which scavenged intracellular ROS.
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Introduction
Alzheimer’s disease (AD) is an irreversible neurodegenerative
disorder of the brain characterized by the progressive cognitive
decline with a poor outcome and unknown etiology. Neuropatho-
logically, AD is defined by an accumulation of extracellular senile
plaques and intracellular neurofibrillary tangles, regionalized
neuronal death and loss of synaptic connections within selective
brain regions. It has been proposed that oxidative stress and
dysfunction of neurogenesis play important roles in the pathogen-
esis of AD [1,2].
It has already been shown that neurogenesis occurs in the adult
mammalian brain and plays roles in both learning and memory
processes and also recovery from injury [3,4]. Abnormalities in
neurogenesis may lead to disorders of learning and memory in
humans such as AD [5]. Studies indicated that many AD risk
factors which are associated with cognitive impairments also
significantly affect hippocampal neurogenesis [3,4,6]. In various
rodent models of AD, including mice with mutation in amyloid
precursor protein or presenilin 1, severe impairment of neurogen-
esis in the subgranular zone of the dentate gyrus has been reported
[6,7]. In the hippocampus of patients with AD, a compensatory
enhancement of neurogenesis has been observed, but this
enhanced neurogenesis is not able to compensate for severe
neuronal loss [2,8]. The therapeutic effects of some AD drugs have
also been ascribed to their ability to increase cerebral neurogenesis
both in vitro and in vivo [9]. All these findings suggest that impaired
neurogenesis may attribute to the pathogenesis of AD. Measures to
enhance neurogenesis therefore have huge therapeutic potentials,
and abnormal neurogenesis is a promising therapeutic target for
this disease [10].
Mounting evidence has also indicated the involvement of
oxidative stress in the pathogenesis of the disease. It has been
shown that free radicals and oxidative stress induce memory
deficits and hence behavioral impairments in AD patients [11,12].
The reactive oxygen species (ROS), which are formed during
oxidative stress, induces cellular and molecular abnormalities in
sporadic AD [13]. Although the exact mechanisms underlying
these deleterious effects remain unclear, it has already been known
that oxidative stress occurs before the formation of neurofibrillary
tangles and senile plaques, both of which are hallmarks of AD
[14,15]. An accumulation of free radicals as a result of an
imbalance between their production and removal by the
antioxidant system may lead to increases of lipid and protein
peroxidation, DNA oxidation and calcium dysregulation, all of
which eventually lead to neuronal cell death [16,17]. Importantly,
oxidative stress has also been considered to be able to affect
neurogenesis [18]. Environmental stresses including exposure to
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with the onset of cognitive impairments [19,20]. Consumption of
potent antioxidants, e.g. melatonin and polyunsaturated fatty
acids, could have a significant effect in reducing the decline of
neurogenesis and attenuating the impairment of cognitive
functions [21,22].
Medicinal plant Rhodiola crenulata (R. crenulata) grows at high
altitudes in the Arctic and mountainous regions, and is commonly
used in phytotherapy in China, Uzbekistan and other Asian
countries. It has been known to be able to stimulate the nervous
system, alleviate depression, enhance work performance, eliminate
fatigue and prevent altitude sickness [23]. Extracts of R. crenulata
have been shown to possess stress-protective and anti-oxidative
activities, and ingestion of the plant extracts from the genus
Rhodiola may improve cognitive functions [24,25], reduce mental
fatigue [26], mitigate free radicals and oxidative insults [27–29]
and enhance neuroprotective [24] and anti-depressive activities
[30]. Phytochemical investigations revealed that the R. crenulata
root contains about 21 compounds. Salidroside (rhodioloside),
rosavins and p-tyrosol are thought to be the most important
constituents for the therapeutic activities of the plant [31,32].
Among these, salidroside has been found to have marked
antioxidant effects and its activity in scavenging superoxide
radicals is concentration- and time-dependent [33]. Salidroside
also has protective effects against hydrogen peroxide-induced
apoptosis in SH-SY5Y human neuroblastoma cells [34].
Although the medicinal plant genus Rhodiola has been known to
have significant anti-oxidative and neuroprotective properties,
there are no reports on its effects on the neurogenesis in AD, and
much remains unknown about its action mechanism and active
ingredients. The aim of this work was to determine whether the
impaired hippocampal neurogenesis in a rat model of AD induced
by the intracerebroventricular (ICV) injection of streptozotocin
(STZ) can be rescued by the pre-treatment with a R. crenulata
extract (RCE), and to determine whether salidroside, a main
ingredient of the RCE which protects neural stem cells (NSCs) by
scavenging ROS, contributes to the protective effect of the RCE on
neurogenesis.
Results
In Vivo Studies
To study the protective effects of R. crenulata on AD, an alcohol
extract (RCE) was first prepared, and adult rats were then treated
with the RCE by gavage everyday for three weeks before AD was
induced by bilateral stereotactic injections of streptozotocin to
both sides of the cerebral ventricles. It was found that pre-
treatment of the RCE resulted in enhanced neurogenesis and
decreased oxidative stress in the hippocampus of AD rats.
(i) RCE Enhanced Neurogenesis in the Hippocampus of
STZ-treated Rats. To assess neurogenesis, brain sections
through the hippocampus labeled with BrdU were double-
stained with BrdU (proliferation marker) and Tuj1 (immature
neuronal marker) antibodies. In rats only treated with STZ, both
the percentage of differentiating neurons (BrdU
+Tuj1
+ double
positive cells amongst all BrdU
+ cells, Figure 1B-B0 and F) and the
total number of dividing cells (BrdU
+ cells, Figure 1B-B0 and G)
were significantly decreased, as compared with those for the
normal control group (p,0.05) (Figure 1A-A0, F and G). These
decreases were however significantly reduced by the pre-treatment
with different doses of the RCE when compared to the STZ-
treated group (p,0.05) (Figure 1B-B0, C-C0, D-D0, E-E0, F and
G), although a complete restoration to the normal control levels
(without STZ treatment) of neurogenesis was not achieved
(Figure 1F and G). Our findings indicated that neurogenesis in
the STZ-treated rats was decreased and this decrease could be
partially rescued by the pre-treatment with the RCE.
(ii) RCE Reduced Oxidative Stress in the Hippocampus of
STZ-treated Rats. To assess oxidative stress in the
hippocampus, we measured spectrophotometrically both the
activity of glutathione reductase (GR) and the amount of
reduced glutathione (GSH) as the measurements for the activity
of glutathione antioxidant system. We also measured the amount
of malondialdehyde (MDA) as the indicator of the level of lipid
peroxidation in the hippocampal tissue. We found that the activity
of the glutathione antioxidant system as reflected by the activity of
GR and the amount of GSH was markedly decreased in STZ-
treated rats as compared to the normal control group (p,0.05)
(Figure 2A and B), and these decreases were accompanied by a
significant increase in the level of lipid peroxidation as indicated by
the increased amount of MDA (p,0.05) (Figure 2C). Pre-
treatment with different doses of the RCE for 3 weeks before the
induction of AD by STZ significantly reduced the decrease of the
activity of the glutathione system and suppressed the elevation of
MDA in STZ-treated rats, especially in the group pre-treated with
a medium dose of the RCE (M-RCE) as compared to the STZ
group (p,0.05) (Figure 2A, B and C). The results demonstrated a
prominent anti-oxidative effect of the RCE on the hippocampus of
the rat model of AD induced by STZ injections.
In Vitro Studies
Next, we sought to determine the cellular mechanism
underlying the protective activities of the RCE against the
impaired neurogenesis in the hippocampus of STZ-treated rats.
We first found that salidroside was the main ingredient of the RCE
(Figure 3) and subsequently procured a pure preparation of
salidroside (Figure 4) for the studies of the effects of salidroside on
neural stem cells (NSCs) from the hippocampus in vitro.
(i) Optimal Doses of STZ and Salidroside for NSC
Culture. Hippocampal cells of newborn rats were isolated
and cultured in DMEM/F-12 serum-free medium supplemented
with B27 and bFGF. One week after culture, they aggregated
and formed spheroid neurospheres (Figure 5A–C, D). Immu-
nofluorescence staining revealed that cells within neurospheres
were immunoreactive to nestin (marker of neural stem cells)
(Figure 5A–C). Neurospheres continued to grow and were
passaged once a week. When a culture medium with 10% fetal
bovine serum but without bFGF (i.e. differentiation medium)
and an adhesive culture surface were used, cells derived from the
neurospheres became immunoreactive to Tuj1 (immature
neuronal marker) (Figure 5E), myelin oligodendrocyte specific
protein (MOSP, oligodendrocyte marker) (Figure 5F) and glial
fibrillary acid protein (GFAP, astrocyte marker) (Figure 5G).
These observations suggested that neurospheres derived from the
hippocampus exhibited active proliferation, self-renewal (i.e.
continuous growth of neurospheres and cell divisions within
neurospheres for many passages) and multipotent properties in
vitro.
Our in vivo studies indicated that the intracerebroventricular
injection of STZ to rats impaired neurogenesis and induced
excessive oxidative stress in the hippocampus. It is thus speculated
that STZ exerted a cytotoxic effect through oxidative damages on
neural stem cells (NSCs) which are thought to be important for
neurogenesis within the hippocampus. To determine the cytotox-
icity of STZ and its optimum dose for the subsequent experiments,
NSCs were treated with increasing concentrations of STZ for
4 hours and examined with the MTT assay (Figure 6A). A dose-
response curve for the cytotoxicity of STZ on NSCs was obtained,
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Formula two, see Materials and Methods). Considering the mild
protective effects of salidroside, we chose a concentration of 8 mM
STZ for all subsequent experiments.
Previous studies revealed that salidroside protected neuronal
cells against apoptosis induced by oxidative stress [34] and
hypoglycemia and cytotoxicity induced by low concentrations of
serum [35], but the effects of salidroside on undifferentiated cells,
particularly NSCs, have not been examined. To this end, we
incubated hippocampus-derived NSCs with increasing concentra-
tions of salidroside and monitored the viability of the cells with the
MTT assay. Our findings showed that direct incubation with
Figure 1. BrdU/Tuj1 double immunofluorescence labeling in the rat hippocampus. (A–E, A9–E9,A 0–E0) Representative photomicrographs
of BrdU (red fluorescence in the nuclei, A–E) and Tuj1 labeling (green fluorescence in the cytoplasm, A9–E9;A 0–E0 are merged images of BrdU and Tuj1
labeling) from different experimental groups: (A–A0) Normal control group, (B–B0) streptozotocin-treated (STZ) group, (C–C0) Low dose of RCE pre-
treatment followed by STZ treatment group (L-RCE+STZ), (D–D0) Medium dose of RCE pre-treatment followed by STZ treatment group (M-RCE+STZ)
and (E–E0) High dose of RCE pre-treatment followed by STZ treatment group (H-RCE+STZ). The upper right inset of the photomicrograph is the
enlarged view of a double-labeled cell in the boxed area (arrow). (F) Bar chart showing the percentages of differentiating neurons (BrdU
+Tuj1
+/
BrdU
+6100%). (G) Bar chart showing BrdU-positive cell counts. Values are expressed as mean6SD. a: p,0.05 compared with the normal control
group; b: p,0.05 compared with the STZ group.
doi:10.1371/journal.pone.0029641.g001
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viability of NSCs (Figure 6B), but when the cells were pre-
incubated with various concentrations of salidroside for 12 hours
and then subject to 8 mM STZ for 4 hours, we found that the
viability of NSCs was significantly higher at higher pre-incubation
concentrations of salidroside (Figure 6C), suggesting that pre-
incubation with salidroside protected NSCs against STZ-induced
injury. Since salidroside at 1 mM was shown to significantly
increase cell viability (Figure 6C), the concentration of 1 mM
salidroside was chosen for the subsequent experiments.
With the MTT assay, we demonstrated in the aforementioned
experiments that the 12-hour pre-incubation with 1 mM of
salidroside significantly protected NSCs from the cytotoxicity
induced by the 4-hour treatment of 8 mM of STZ. Based on this
information, we then performed a full survey on the effects of
salidroside on NSCs following STZ-induced injury.
(ii) STZ Decreased NSC Survival, Proliferation and
Neuronal Differentiation but Increased ROS. The results
of the MTT assay described above revealed that STZ was
cytotoxic to NSCs. Next, we further examined the effects of STZ
on cell survival, proliferation and neuronal differentiation of
NSCs. NSCs were first incubated with 8 mM STZ for 4 h and
then further incubated with the culture medium without STZ for
another 8 h before the culture was examined under a light
microscope. In the normal control group without incubation with
STZ, NSCs attached to the culture surface, flattened and extended
cellular processes (Figure 7A). When the culture was treated with
STZ, many NSCs aggregated into clusters, which then detached
from the culture surface (Figure 7B). Some of them managed to
attach but they seldom extended elongated cellular processes. To
determine the levels of necrosis and apoptosis, the cells were
stained for annexin V (marker for early to intermediate stages of
apoptosis) and propidium iodide (PI) (marker for late stage of
apoptosis and necrosis) and also cleaved caspase-3 (marker for the
advanced stage of apoptosis). The results showed significant
increases of annexin V and PI positive cells in the STZ-treated
group as compared to the normal control group (p,0.05)
(Figure 8A, B, G, H). Immunostaining for caspase-3 (cleaved
form) also demonstrated a significant increase in the percentage of
caspase-3 positive cells in the STZ group when comparing to the
normal control group (p,0.05) (Figure 9A-A0, B-B0, G), indicating
that STZ induced an increase of apoptotic activity in the NSC
culture. Then, the effects of STZ on bFGF-stimulated NSCs
proliferation and FBS-induced neuronal differentiation of NSCs
were studied by immunostaining for BrdU, Tuj1, MAP2 and
NF150. Our results demonstrated that the percentages of cells
immunoreactive to BrdU (Figure 10A-A0, B-B0, G), MAP2, NF150
or Tuj1 (Figure 11A, B, G, H, M, N, S) were all significantly lower
in the STZ group than those in the normal control group (p,0.05)
(Figures 10G and 11S). In conclusion, STZ increased cell death,
decreased proliferation and reduced neuronal differentiation of
NSCs, all of which might contribute to the impaired neurogenesis
in vivo induced by the ICV injection of STZ.
Previous studies revealed that STZ-mediated production of
hydroxyl radicals and ROS was crucial to the STZ-induced
pancreatic beta cell damage in vitro [36]. Likewise, our study in vivo
also found that the ICV injection of STZ resulted in the
impairment of neurogenesis accompanied with an increase of
oxidative stress in the hippocampus (see In Vivo Studies (i) and (ii)).
These observations prompted us to explore whether there was an
increase of cellular ROS levels in STZ-treated NSCs. Results
indicated that incubation of NSCs with STZ elicited a striking
increase of cellular ROS, which was immunoreactive to the green
fluorescent probe carboxy-H2DCFDA, in the STZ group
Figure 2. Oxidative stress in the hippocampus of STZ-treated rats. (A) Activities of glutathione reductase (GR). (B) Amounts of reduced
glutathione (GSH). (C) Amounts of malondialdehyde (MDA). Values are expressed as means6SD. a: p,0.05 compared with the normal control group;
b: p,0.05 compared with the STZ group. Normal Control: normal control group; STZ: streptozotocin-treated group; L-RCE+STZ, M-RCE+STZ and H-
RCE+STZ: pre-treatment groups with low, medium and high concentrations of the R. crenulata extract (RCE), respectively, followed by STZ treatment.
doi:10.1371/journal.pone.0029641.g002
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(Figure 12A-A9)( p,0.05, Table 1). Our findings thus implicated
ROS-mediated toxicity induced by STZ in NSCs.
(iii) H2O2 Exhibited Similar Effects on NSC Survival,
Proliferation, Neuronal Differentiation and ROS
Levels. To further verify that the cellular activities of STZ is
mediated through ROS, we incubated NSCs with a well-known
oxidant, H2O2, in replacement of STZ. As expected, H2O2
significantly reduced cell viability (Figure 7C, G), increased
necrotic and apoptotic cells (Figure 8C, G, H; Fig. 9C-C0,G )
and decreased BrdU labeled cells (Figure 10C-C0, G) and MAP2,
NF150 and Tuj1 immunoreactive cells (Figure 11C, I, O, S). Most
importantly, H2O2 also concomitantly increased cellular ROS
levels (Figure 12C-C9, Table 1), as compared to the normal control
group (p,0.05).
(iv) Catalase Pre-incubation Attenuated STZ Cellular
Activities. To confirm the involvement of ROS in the cellular
activities of STZ on NSCs, catalase, an H2O2 scavenger, was used
to rescue NSCs from STZ’s effects on inducing ROS formation.
Pre-incubation of NSCs with catalase markedly reduced the
generation of ROS induced by STZ (Table 1, Figure 12A-A9,D -
D9) and reduced necrosis and apoptosis (Figure 8D, G, H;
Figure 9D-D0, G) with significant increases of viability,
proliferation, and neuronal differentiation of NSCs (Figures 7D,
Figure 3. Analytical HPLC chromatograms. (A) R. crenulata extract (RCE); (B) salidroside control. Note that salidroside is the most abundant
ingredient of the RCE.
doi:10.1371/journal.pone.0029641.g003
Figure 4. HPLC chromatogram of salidroside. Note that the preparation of salidroside is 100% pure.
doi:10.1371/journal.pone.0029641.g004
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demonstrated that STZ exerted its cellular activities on NSCs
through the generation of cellular ROS.
(v) Salidroside Pre-incubation Similarly Attenuated STZ
Cellular Activities and Reduced ROS Levels. As for the
antioxidant catalase, we also found that salidroside pre-incubation
in the salidroside+STZ group, as compared with the STZ group,
significantly attenuated STZ activities, which included the
decrease of viability (Figure 7E, G), reduction in the percentages
of annexin V and PI labeled cells (Figure 8E, G, H) and caspase-3
immunoreactive cells (Figure 9E-E0, G), increase of BrdU labeling
(Figure 10E-E0, G) and increase of the percentages of MAP2,
NF150 and Tuj1 positive cells (Figure 11E, K, Q, S). Our results
clearly demonstrated that salidroside significantly protect NSCs
from STZ-induced cellular activities.
As alluded to earlier, salidroside possesses pronounced anti-
oxidative properties [33,34], and hence it is important to know
whether salidroside would reduce oxidative stress in NSCs induced
by STZ. It was found that pre-incubation with salidroside resulted
in a significant decrease of cellular ROS in the salidroside+STZ
group as compared with the STZ group (p,0.05) (Table 1,
Figure 12E-E9). Our results therefore strongly suggested that
salidroside reduces the cellular effects of STZ on NSCs by
scavenging ROS.
(vi) Null Cytotoxicity but Enhancing Effect of Salidroside
on the Extension of Cellular Processes from NF Positive
Cells Derived from NSCs. As compared to the normal control
group, the group treated with salidroside only (salidroside blank
group) did not exhibit significant differences in the viability assay
(Figure 7F, G), annexin V and PI labeling (Figure 8F, G, H),
caspase-3 immunoreactivity (Figure 9F-F0, G), BrdU labeling
(Figure 10F-F0, G) and immunolocalization of MAP2, NF150 or
Tuj1 (Figure 11F, L, R, S), indicating that salidroside alone did not
exhibit any cellular effects on NSCs.
Although salidroside did not alter the percentages of MAP2,
NF150 and Tuj1 immunoreactive cells, it was intriguing to observe
that the average length of cellular processes extending from NF150
positive cells was significantly increased in the group treated with
salidroside only (salidroside blank group) as compared to the
normal control group (p,0.05) (Figure 11G, L, T). The result
appeared to suggest that salidroside possesses an enhancing effect
on the extension of cellular processes from differentiating neurons.
Discussion
R. crenulata has been previously studied in our laboratory, and an
alcohol extract from the root of this medicinal plant has been
demonstrated to be effective in improving cognitive functions in
Figure 5. Neurosphere culture derived from the rat hippocampus. (A–C) Neurosphere at the second passage is immunoreactive to nestin, a
marker of neural stem cells (green), and counterstained by nuclear fluorescent stain Hoechst33342 (blue). (D) Hippocampal cells from newborn rats
proliferated and aggregated to form neurospheres one week after cultured in the DMEM/F-12 serum-free medium supplemented with B27 and bFGF.
(E–G) Cells from the neurospheres show positive immunoreactivity to Tuj1 (E), MOSP (F), and GFAP (G) (markers of differentiating neurons,
oligodendrocytes and astroglia, respectively) one week after cultured in the differentiation medium (DMEM/F12+10% FBS).
doi:10.1371/journal.pone.0029641.g005
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injection of streptozotocin (STZ) [24]. This extract has also been
shown to be able to enhance hippocampal cell proliferation in
depressive rats induced by chronic mild stress [30,37]. Other
studies showed that this medicinal plant possesses potent
antioxidative activities [29,33]. With these antioxidative activities,
R. crenulata has been regarded as being capable of protecting the
nervous system from oxidative damage inflicted by free radicals,
rescuing neural stem cells (NSCs) within the nervous system from
apoptosis or necrosis, and hence improving neurogenesis. Our
previous study has already shown that continuous consumption of
the alcohol extract of R. crenulata (RCE) reduced oxidative stress in
the brain and prevented decline of learning and memory abilities
caused by STZ in rats [24]. However, it still remains unknown as
to what ingredient of the extract induces these neuroprotective
effects and through what kind of cellular mechanism this
ingredient exerts these effects. In the present study, we showed
that pre-treatment with the RCE significantly improved neuro-
genesis in the hippocampus of the AD rats induced by ICV
injections of STZ, as evidenced by the increased numbers of BrdU
and Tuj1 immunoreactive cells when compared to those in the AD
rats without the RCE pre-treatment. Concomitant with this
improved neurogenesis, a reduction of oxidative stress was also
observed. We then demonstrated in our in vitro experiments that
when NSCs isolated from the hippocampus were exposed to STZ,
significant increases of intracellular reactive oxygen species (ROS)
was observed. Similar increases of hydroxyl radicals and ROS in
the STZ-induced damage of pancreatic beta cells in vitro have also
been reported [36]. We further demonstrated that these increased
ROS levels were closely associated with the reduction of viability,
proliferation and differentiation of NSCs. These cellular changes
induced by STZ could be reproduced with the potent oxidant
hydrogen peroxide and suppressed with pre-incubation of the
antioxidant catalase. Pre-incubation of these STZ-treated NSCs
with salidroside, the main ingredient of the RCE, similarly
suppressed these cellular changes resulting in decreases of
intracellular ROS with simultaneous reduction of cell death and
enhancement of cell proliferation and neural differentiation of
hippocampal NSCs. Our observations therefore implicated that
salidroside exerted its neuroprotective effects on STZ-induced
NSC injuries via its capability of scavenging ROS. Since NSCs are
thought to be responsible for the neural repair through
neurogenesis and associated with learning and memory recovery
following CNS injury, it is likely that R. crenulata improves
neurogenesis in vivo by protecting NSCs from cytotoxic injuries,
and these neuroprotective effects can be ascribed to the ROS
scavenging activity of salidroside.
STZ is a glucosamine-nitrosourea compound which generates a
cytotoxic metabolite capable of preferentially destroying beta cells
in pancreatic islets [38]. An ICV injection of a sub-diabetogenic
dose of STZ to rats has been found to cause prolonged
disturbances of brain glucose and energy metabolism by
desensitizing neuronal insulin receptors [39]. Subsequently, these
disturbances result in decreases in choline acetyltransferase levels
and increased oxidative stress in the hippocampus, leading to
impairments in learning and memory [40,41]. However, STZ has
no effect on blood glucose when given by ICV injections [42],
implicating that its action is independent of hyperglycemia. Recent
studies found that the rat model with ICV injection of STZ is able
to mimic the cellular and molecular abnormalities including
hyperphosphorylation of Tau protein and senile plaque-like
deposits of sporadic AD [42,43]. In fact, the ICV injection of
STZ has already been widely used as an experimental method to
induce different types of neurodegenerative diseases, including AD
[40,44], in experimental animals.
Many studies indicated that salidroside, the main bioactive
compound of Rhodiola plants, possesses anti-oxidative properties
and thus contributes to the neuroprotective activities of the
Figure 6. Viability of NSCs, as assayed by the MTT, at various doses of STZ and salidroside. (A) Cells from neurospheres at the second
passage were incubated with various concentrations of STZ for 4 hr. STZ exhibits a dose-dependent cytotoxic effect on NSCs. (B) Salidroside at a
concentration up to 2 mM for 12 hr shows no cytotoxic effects on NSCs. (C) Cells from neurospheres were pre-incubated with various concentrations
of salidroside for 12 hr before exposure to 8 mM STZ. Salidroside at 1 or 2 mM exhibits significant protection against STZ-induced cytotoxity on NSCs.
*p,0.05 compared with the control value without salidroside. Values are expressed as means6SD.
doi:10.1371/journal.pone.0029641.g006
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demonstrated to be able to stimulate erythropoiesis [45], enhance
hippocampal cell proliferation [30] and promote differentiation of
mesenchymal stem cells into hepatocytes [46]. In our in vitro
studies, we found that incubation with salidroside alone did not
affect cell viability, proliferation and neuronal differentiation of
NSCs derived from the hippocampus, but protected them against
STZ-induced cell death and reduction of proliferation and
differentiation by depleting the intracellular ROS. In addition to
these prominent ROS scavenging activities demonstrated in this
study, salidroside may also exert its neuroprotective activities
through other potential pathways: (a) modulation of apoptosis-
related processes by alteration of the expression of cell death
related genes including down-regulation of the pro-apoptotic gene
Figure 7. Cell morphology (A–F) and cell viability as measured by the MTT assay (G). NSCs at the second passage were seeded on poly-L-
lysine-coated culture plates and grouped for the following treatments: (A) Normal control group without any treatment; (B) STZ group treated with
STZ for four hours; (C) H2O2 control group treated with H2O2 for four hours; (D) Catalase+STZ group treated with catalase for twelve hours followed
by four-hour incubation with STZ; (E) Salidroside+STZ group treated with salidroside for twelve hours followed by four-hour incubation with STZ; (F)
Salidroside blank group treated with salidroside for twelve hours. Values are expressed as mean6SD.
a p,0.05 compared with the normal control
group;
b p,0.05 compared with the STZ group.
doi:10.1371/journal.pone.0029641.g007
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Bcl-X(L) [34,35], restoration of the mitochondrial membrane
potential [47,48] or/and suppression of cytochrome c release
and caspase cascade activation [49]; (b) suppression of both the
excessive entry and release of Ca
2+ from the intracellular
calcium stores, hence leading to an inhibition of the elevation of
intracellular calcium levels [34,50,51]; and (c) inhibition of
nitric oxide (NO) synthase activity and reduction of NO
production by inhibition of the NF-kB-iNOS-NO signaling
pathway [52–54]. Whether all these pathways or only some of
them play roles in the neuroprotective activities of salidroside
awaits further investigations.
Figure 8. Annexin V and PI immunolabeling for detection of apoptosis and necrosis in NSCs, respectively. (A–F) Representative
fluorescence photomicrographs of NSCs immunoreactive to annexin V (green) and PI (red) with their nucleus counterstained with Hoechst33342
(blue) in six experimental groups: (A) Normal control group; (B) STZ group; (C) H2O2 control group; (D) Catalase+STZ group; (E) Salidroside+STZ group;
(F) Salidroside blank group. Cell at early to intermediate stages of apoptosis are positive to Annexin V but negative to PI (open arrow); late apoptosis
cells are PI positive with chromatin condensation; and necrotic cells are PI positive without chromatin condensation (solid arrow). (G) Bar chart
showing the percentages of annexin V-positive cells which are at the early-to-intermediate stage of apoptosis. (H) Bar chart showing the percentages
of PI-positive cells, indicating that they are either late apoptotic or necrotic cells. Values are expressed as mean6SD. Numbers within bars represent
the actual numerical reading on the y-axis.
a p,0.05 compared with the normal control group;
b p,0.05 compared with the STZ group.
doi:10.1371/journal.pone.0029641.g008
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29641Figure 9. Immunofluorescence staining for cleaved caspase-3 (p17/19 active fragments) on NSCs. (A–F, A9–F9,A 0–F0) Representative
photomicrographs of caspase-3 immunoreactive cells (A–F) with their nuclei counterstained by the blue fluorescent nuclear stain Hoechst33342 (A9–
F9) in six experimental groups: (A-A0) Normal control group, (B-B0) STZ group, (C-C0)H 2O2 control group, (D-D0) Catalase+STZ group, (E-E0)
Salidroside+STZ group and (F-F0) Salidroside blank group. (G) Bar chart showing the percentages of caspase-3 immunoreactive cells. Values are
expressed as mean6SD. Numbers within bars represent the actual numerical reading on the y-axis.
a p,0.05 compared with the normal control
group;
bp,0.05 compared with the STZ group.
doi:10.1371/journal.pone.0029641.g009
Figure 10. BrdU labeling in NSCs. NSCs at P2 were labeled with BrdU (10 mM) for 4 h63 times (three times each for 4 hours), and then
immunofluorescently stained for BrdU. (A–F, A9–F9,A 0–F0) Representative photomicrographs of BrdU labeled cells (red, A–F) with their nuclei
counterstained by the nuclear fluorescent stain DAPI (blue, A9–F9) in six experimental groups: (A-A0) Normal control group, (B-B0) STZ group, (C-C0)
H2O2 control group, (D-D0) Catalase+STZ group, (E-E0) Salidroside+STZ group and (F-F0) Salidroside blank group. (G) Bar chart showing the
percentages of BrdU labeled cells. Values are expressed as mean6SD.
a p,0.05 compared with the normal control group;
b p,0.05 compared with
the STZ group.
doi:10.1371/journal.pone.0029641.g010
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neurogenesis and oxidative stress were observed in our in vivo
experiments with the RCE but similar dose responses were not
found in vitro with salidroside. Other in vivo observations with
similar bell-shaped dose responses have also been reported
[55,56]. They found that administration with an extract of the
medicinal plant of the genus Rhodiola at a dose of 0.1 mL improved
both learning and memory in rats, while doses at 0.02 and 1.0 mL
did not cause any substantial improvement. It is likely that the
decline of the activity of the extract at higher doses might be
attributed to the presence of some other ingredients which may
interfere with neuroprotective actions of the extract. Even when
the herbal extract is quantified with known active or marker
compounds to achieve more consistent pharmaceutical properties,
variations in the concentrations of other constituents can affect its
activities and biological efficacies [57]. Conversely, we also cannot
exclude the possibility that some other components of the RCE
may also account for the neuroprotective effects of R. crenulata. The
root of the medicinal plant R. crenulata contains more than 21
compounds. Besides salidroside, p-tyrosol is another important
active constituent of the plant [31,32]. Tyrosol has been relatively
well studied as the main ingredient of some other dietary food such
as white wine and olive oil [58–61], and a variety of cellular
activities of tyrosol including antioxidant activity [59,62], neural
protective functions [61] and anti-inflammatory effects [60] have
been reported. Hence tyrosol might also exert its neuroprotective
effects through its antioxidant activity, just like salidroside. If
tyrosol is also found to exhibit neuroprotective activities on NSCs,
then the combined activities of salidroside and tyrosol may
attribute to the protective actions of the RCE.
The deposits of beta amyloid protein (Ab) and hyperpho-
sphorylation of Tau protein in brain regions are the main
pathological hallmarks of AD, and these proteins elicit the
pathological cascade responsible for dementia, neuropsychiatric
changes and finally death of neurons. The ICV administration of
STZ also leads to an increase in the total Tau and Ab protein
[42,43], in addition to the free radical formation [40]. It is
therefore of special interest in investigating the changes of Ab or
phosphorylated Tau protein levels in the STZ-treated and RCE-
protected rats. Studies have already indicated that Ab might cause
deterioration of the brain microenvironment which is important
for neurogenesis of NSCs [63,64]. A recent study also showed that
salidroside has protective effects against Ab-induced oxidative
stress in SH-SY5Y human neuroblastoma cells [48]. To better
understand the neuroprotective activities of the RCE,i ti s
imperative to determine the potential protective actions of
salidroside against defective neurogenesis caused by Ab in future
studies.
Intriguingly, although salidroside did not seem to be able to
induce overt neuronal differentiation of NSCs, it exhibited an
enhancing effect on the extension of cellular processes from some
neuron-like cells derived from NSCs in this study. This suggests
Figure 11. Immunofluorescence staining for MAP2, NF150 and Tuj1 in NSCs. (A–R) Representative photomicrographs of immunoreactive
cells (green, nuclei counterstained with blue fluorescent stain Hoechst33342) for MAP2 (A–F), NF150 (G–L) and Tuj1 (M–R) in six experimental groups:
Normal control group (A, G, M), STZ group (B, H, N), H2O2 control group (C, I, O), Catalase+STZ group (D, J, P), Salidroside+STZ group (E, K, Q) and
Salidroside blank group (F, L, R). (S) Bar chart showing the percentages of immunoreactive cells for MAP2, NF150 and Tuj1. (T) Bar chart showing the
average length of cellular processes from NF150 immunoreactive cells. Values are expressed as mean6SD.
a p,0.05 compared with the normal
control group;
b p,0.05 compared with the STZ group.
doi:10.1371/journal.pone.0029641.g011
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newly developed neurons, although more investigations need to be
carried out to confirm this observation.
Taken together, salidroside, as one of the main bioactive
ingredients of R. crenulata, most probably acts by scavenging ROS
to protect NSCs from necrosis and apoptosis, and also improve
proliferation and neuronal differentiation of NSCs in the
hippocampus of STZ-treated rat. All these contribute to the
protective effects of the RCE on defective neurogenesis and
cognitive impairment in AD rats. Our findings raise the possibility
Figure 12. Detection of intracellular ROS with a fluorescent probe carboxy-H2DCFDA. Representative photomicrographs showing ROS
(reactive to the green fluorescent probe carboxy-H2DCFDA) within the cytoplasm of NSCs (A–E) and merged images showing both ROS
immunoreactivity and cell morphology (A9–E9) in five experimental groups: Normal control group (A-A9), STZ group (B-B9), H2O2 control group (C-C9),
Catalase+STZ group (D-D9) and Salidroside+STZ group (E-E9).
doi:10.1371/journal.pone.0029641.g012
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pal neurogenesis and thus treating AD.
Materials and Methods
Chemicals
The sources of different chemicals, reagents and assays kits are
listed below: Salidroside (.98%) from Tianjin Jianfeng Natural
Product R&D Co., Ltd.; Glutathione reductase (GR), reduced
glutathione (GSH) and malondialdehyde (MDA) detection kits and
Coomassie brilliant blue protein assay kit from Nanjing Jiancheng
Bioengineering Institute (Jiangsu province, China); Sodium
carboxymethycellulose (CMC-Na) from Tianjin Fuchen Chemical
Reagent Factory (Jiangsu province, China); Streptozotocin,
Hoechst33342 and 5-bromo-29-deoxyuridine (BrdU) from Sigma
Chemical Co., St. Louis, USA; Catalase, H2O2,4 9,6-diamidino-2-
phenylindole (DAPI) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyl-tetrazolium bromide (MTT) from Amresco Inc.; Dulbecco’s
modified Eagle’s medium/F12 (DMEM/F12) (1:1), bFGF, B27
and fetal bovine serum (FBS) from GIBICO, Invitrogen Inc;
Annexin V Apoptosis Detection Kit (sc-4252 AK) from Santa
Cruz Biotechnology, Inc.; Image-iT
TM LIVE Green Reactive
Oxygen Species Detection Kit (I36007) from Molecular Probes,
Invitrogen Inc. All other reagents were purchased from Sigma
Chemicals and were of analytical grade unless stated otherwise.
R. Crenulata Extract (RCE)
An alcohol extract of the edible R. crenulata root was used in this
study. The R. crenulata used for extraction was obtained from
Guangzhou Baoxing Bio-technologies Co., LTD (China), and was
authenticated by a plant taxonomist. The root of the plant was first
dried and ground with a grinder, and the coarse powder of the
plant was then extracted with 70% alcohol twice, 2 hr each. The
extract was condensed by vacuum, then collected with ethanol
precipitation, and finally spray dried to yield a reddish-brown
powder. The yield of the R. crenulata extract was about 3–5% (w/
w). The concentration of the known active component salidroside
in the extract was determined by HPLC and was found to be 4%
w/w.
Animals
Male Sprague Dawley rats weighing 240–260 g were used in vivo
while in vitro studies were conducted on primary hippocampal
neural stem cells (NSCs) prepared from newborn rats at postnatal
day zero (P0). All the animals were purchased from the
Experimental Animal Center of Sun Yat-sen University, Guangz-
hou, China. Rats were fed with standard chow diet and tap water
ad libitum, and housed in pair in separate cages which were
maintained at a temperature of 2462uC under 50–60% relative
humidity with 12 h light/dark cycles throughout the experiment.
The animals were kept in the facility for at least 1 week before the
experiment started. Rats were then divided into five groups as
indicated in the following section. All experimental protocols and
animal handling procedures adopted in the present study were
approved by the Animal Care and Use Committee of Sun Yat-sen
University and were consistent with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Grouping and Treatments In Vivo
Rats were divided randomly into five groups of 12 animals:
normal control group (injected with an artificial cerebrospinal fluid
which was also the solvent for STZ. For components of the fluid,
see next section), STZ group (injected with STZ only), L-
RCE+STZ group (pre-treatment with a low dose of 1.5 g/kg
RCE and then STZ treatment), M-RCE+STZ group (pre-
treatment with a medium dose of 3.0 g/kg RCE and then STZ
treatment) and H-RCE+STZ group (pre-treatment with a high
dose of 6.0 g/kg RCE and then STZ treatment). The RCE (R.
crenulata extract) was diluted with 0.5% CMC-Na water solution
and given orally everyday at a single dose of 2 ml by gavages for
21 days before the STZ injection (see next section). The normal
control and STZ groups of rats received orally the same volume
(i.e. 2 ml) of 0.5% CMC-Na solution for 21 days.
Intracerebroventricular Injection
STZ was injected intracerebroventricularly (ICV) as described
previously [40]. Briefly, rats were anesthetized with sodium
pentobarbital at an intraperitoneal dose of 40 mg/kg. The head
was positioned within a stereotactic frame, and the skull was
exposed. Burr holes were drilled in the skull on both sides over the
lateral ventricles using the following coordinates [65]: 0.8 mm
posterior to the bregma; 1.8 mm lateral to the sagittal suture; and
4.0 mm beneath the surface of skull. Each rat of the STZ group
and the three RCE pre-treatment groups was given bilateral ICV
injections of 1.5 mg/kg STZ. STZ was dissolved in an artificial
cerebrospinal fluid (artificial CSF: 147 mM NaCl, 2.9 mM KCl,
1.6 mM MgCl2, 1.7 mM CaCl2 and 2.2 mM dextrose), and a
STZ solution of 25 mg/ml was freshly prepared on ice just before
the injection. The injections of the same dose of STZ were
repeated on the 3rd day after the first injection on the first day.
Rats of the normal control group underwent the same surgical
procedure and was injected with the same volume of the artificial
CSF (the exact volume was calculated according to the body
weight of individual animal) instead of STZ.
BrdU Administration
In order to study cell proliferation and differentiation in the
hippocampal dentate gyrus, rats received twelve consecutive daily
intraperitoneal injections of BrdU (at 50 mg/kg body weight)
during the period of the 9–20th days after ICV STZ injections.
BrdU was dissolved in 0.9% NaCl and sterilized through a
0.45 mm filter. The animals were sacrificed 24 h after the last
BrdU injection.
Hippocampal Sample Preparations
(i) Hippocampal homogenate. Rats were sacrificed on day
21 after the first ICV injection of STZ. The entire brains were
removed quickly for dissecting the hippocampus on ice. The
hippocampuses were weighed and then homogenized in cold
normal saline to obtain a 10% (w/v) homogenate solution. The
Table 1. Comparison of the intracellular ROS levels in NSCs
for five groups.
Groups RFU (Relative Fluorescent Unit) value*
(a) Normal Control 56.20613.98
(b) STZ 1209.766340.75
(c) H2O2 Control 1330.326432.90
(d) Catalase+STZ 389.33661.08
(e) Salidroside+STZ 309.32653.09
*p,0.05, when value for (b), (c), (d) or (e) compared with value for (a); value for
(d) or (e) compared with value for (b); or value for (d) or (e) compared with value
for (c). One-way ANOVA. Values are expressed as means6SD.
doi:10.1371/journal.pone.0029641.t001
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supernatant was collected, and aliquots were stored at 280uC for
detection of MDA, GR and GSH and the protein assay.
(ii) Hippocampal tissue sections. Three weeks after the
first ICV STZ injection, rats were deeply anaesthetized with
sodium pentobarbital. The animals were fixed by transcardial
perfusion, first with 150 ml normal saline containing heparin
(5 U/mL) and then 250 ml 4% (w/v) paraformaldehyde (PFA) in
0.01 M phosphate buffered saline (PBS, pH7.4). The brains were
dissected and postfixed in the same fixative overnight and
transferred to 30% sucrose solution for cryoprotection. Coronal
sections at 40 mm were cut in a cryostat. Every 12 coronal sections
were selected, and six sections were collected from each rat for the
examination of neurogenesis in the hippocampus.
Indicators for Oxidative Stress in the Hippocampus
According to the instructions of the test kits, the amounts of
malondialdehyde (MDA) and glutathione (GSH) and also the
activity of glutathione reductase (GR) were measured spectropho-
tometrically with the thiobarbituric acid (TBA) method [66], the
method of Ellman [67] and the method of Carlberg and
Mannerviek [68], respectively. The concentrations of MDA and
GSH were expressed as nmol/mg protein and mg/g protein,
respectively. The enzyme activity of GR was quantified at 25uCb y
measuring the decline of NADPH at 340 nm. 1 U of GR was
defined as the amount of GR in 1 g tissue protein which catalyses
1 mM NADPH oxidation per minute. Protein content was assayed
with Coomassie brilliant blue by following the test kit instruction.
The absorbance was measured at 595 nm using a spectropho-
tometer.
Tuj1/BrdU Double Immunofluorescence Labeling
The phenotype of differentiating cells was studied with Tuj1/
BrdU double immunofluorescence labeling described elsewhere
[9,69]. For BrdU detection, DNA was denatured by incubation of
sections for 2 h in 50% formamide/26SSC (0.3 M NaCl and
0.03 M sodium citrate) at 65uC. The sections were then rinsed for
5 min in 26SSC, incubated for 30 min in 2 N HCl at 37uC and
then rinsed again for 10 min in 0.1 M boric acid, pH 8.5. Double
immunofluorescence labeling was performed with the mouse
monoclonal anti-BrdU antibody (Sigma Chemical Co., St. Louis,
USA; 1:400) and rabbit polyclonal anti-bIII tubulin (Tuj1)
antibody (Sigma Chemical Co., St. Louis, USA; 1:60) as the
primary antibodies and FITC- and Cy3-conjugated antibodies as
the secondary antibodies (Jackson Immunological Research; 1:100
for FITC, and 1:400 for Cy3), respectively. Negative controls for
BrdU labeling were performed by using sections of brain tissues
from rats without receiving BrdU injection while for the negative
controls for Tuj1 staining, the primary antibody treatment was
replaced by incubation of PBS (solvent for the antibodies) during
the staining procedure. Sections were mounted with 30% glycerin
in PBS and examined under an epifluorescence microscope (Leica,
Switzerland) equipped with the Leica IM50 Image Plus computer-
assisted image analysis system.
Preparation and Characterization of NSCs
NSCs were prepared from the hippocampal tissue of newborn
rats at postnatal day 0 following our procedure described earlier
[70]. Briefly, the entire hippocampus was dissected and dissociated
in D-Hanks’ balanced salt solution (HBSS). The cell suspension
was centrifuged at 1000 rpm for 5 min. The pellet was then re-
suspended in DMEM/F12 supplemented with B27 (2 ml/100 ml)
and bFGF (20 ng/ml). The cells were plated to 75 ml culture
flasks (final density: 1610
5 viable cells/ml). Half of the medium was
refreshed every three days. Typically, the cells grew as neuro-
spheres in suspension and were passaged approximately once per
week. Throughout the study, neurospheres at the second passage
(P2) were used. To confirm the neurospheres contained nestin
immunoreactive cells, neurospheres were fixed with 4% PFA for
30 min at room temperature, rinsed in PBS, labeled with a
monoclonal antibody to nestin (Sigma Chemical Co., St. Louis,
USA; 1:1000), a marker of neural stem cells [71], and then
incubated with FITC-conjugated anti-mouse IgG (1:100, Jackson
Immunological Research, PA, USA). To examine their neuronal
differentiation potential, P2 neurospheres were directly plated on
poly-L-lysine-coated coverslips and grown in the differentiation
culture medium (DMEM/F12+10% FBS) for seven days. After
fixation with 4% PFA, cultured cells were immunostained for Tuj1
(immature neuron marker), glial fibrillary acidic protein (GFAP)
(astroglia marker, [72]) and myelin oligodendrocyte specific
protein (MOSP) (oligodendrocyte marker), using rabbit polyclonal
anti-bIII tubulin (Sigma Chemical Co., St. Louis, USA; 1:60),
rabbit polyclonal anti-GFAP (Sigma Chemical Co., St. Louis,
USA; 1:300) and mouse monoclonal anti-MOSP (Sigma Chemical
Co., St. Louis, USA; 1:1000) antibodies as primary antibodies,
respectively, followed by incubation with FITC-conjugated anti-
rabbit IgG (1:100, Jackson Immunological Research, PA, USA)
and Cy3-conjugated anti-mouse IgG (1:400, Jackson Immunolog-
ical Research, PA, USA) antibodies as secondary antibodies.
Negative control was performed by omitting the primary
antibodies. The cell nuclei were counterstained with blue
fluorescent stain Hoechst33342 at 10 mg/ml.
In Vitro Tests
To assess the protective effect of salidroside against STZ-
induced cellular activities on NSCs, three different experimental
protocols were employed to determine (i) the effect of different
concentrations of STZ on NSC viability, (ii) the effect of different
concentrations of salidroside on NSC viability and finally (iii) the
protective effect of different concentrations of salidroside against
the cytotoxity induced by STZ on NSCs. In the following
protocols, NSCs at the second passage (P2) were plated on poly-L-
lysine-coated 96-well flat-bottomed plates at 1610
4 cells per well,
and STZ and salidroside were dissolved in warmed DMEM/F12
at the desired concentrations just before addition to NSCs. NSCs
viability was assayed by MTT.
(i) Effect of Different Concentrations of STZ on NSC
Viability. NSCs were incubated with STZ for 4 h at
concentrations of 0.5, 1.0, 2.0, 4.0, 8.0, 16.0 and 32.0 mM as
previously reported [73,74]. Control cells were untreated. Each
sample test was repeated three times in five independent wells.
The NSC growth inhibition ratio (P) was calculated with Formula
one (see below). The half maximal inhibitory concentration (IC50)
of STZ was calculated with Formula two (see below).
Formula one : P~1{ ODexperiment=ODcontrol

Formula two : Lg IC50 ðÞ ~
Lg Xm ðÞ {Lg I ðÞ | Ps{ 3{Pm{Pn ðÞ =4 ½ 
P: inhibition ratio; ODexperiment: optical density (OD) of
experiment well; ODcontrol: OD of control well; Xm: maximal
concentration; I: dilution factor; Ps: sum of inhibition ratio; Pm:
maximal inhibition ratio; Pn: minimal inhibition ratio; Lg:
common logarithm.
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NSC Viability. NSCs were pre-incubated with salidroside for
12 h at concentrations of 0, 1, 10, 100, 250, 500, 1000 and
2000 mM, which were also previously reported [34,35]. Each
sample test was repeated three times in five independent wells.
(iii) Protective Effect of Different Concentrations of
Salidroside against Cellular Activities Induced by STZ on
NSCs. NSCs were pre-incubated with salidroside for 12 hr at
concentrations of 0, 1, 10, 100, 250, 500, 1000 and 2000 mM
before exposure to STZ for 4 h at the IC50 concentration. Control
cells were untreated. Each sample test was repeated three times in
five independent wells. The concentration of salidroside which
exerted the maximal protective effect was used in all subsequent
experiments.
Grouping and Drug Administration in Vitro
NSCs at P2 were seeded on poly-L-lysine-coated cultured plates
and cultured with the plain culture medium alone (Normal
Control group), H2O2 at 1 mM [75] for four hours (H2O2 Control
group), STZ for four hours (STZ group), salidroside for twelve
hours (Salidroside Blank group), salidroside for twelve hours
followed by a four-hour incubation with STZ (Salidroside+STZ
group), or catalase at 50 mg/ml [76] for twelve hours followed by a
four-hour incubation with STZ (Catalase+STZ group). The
culture medium was refreshed with the plain culture medium,
and NSCs were further cultured for 8 h before various assays were
performed. Each experiment was repeated five times.
MTT Viability Assay
MTT assay was used as a general indicator of cellular viability
[77]. Briefly, after various treatments, 20 ml MTT (5 mg/ml) was
added and the culture was incubated for additional 4 hr. The
culture medium was replaced with 150 ml DMSO, and the
absorbance at 490 nm was measured by a Bio-Rad reader (model
680). % Viability of NSCs was calculated with Formula three:
Formula three : % Viability~ ODexperiment=ODcontrol

|100%
Annexin V Labeling
An early indicator of apoptosis is the rapid translocation and
accumulation of the membrane phospholipid phosphatidylserine
from the cytoplasmic interface to the extracellular surface [78].
This morphological change in the plasma membrane was detected
with the Annexin V Apoptosis Detection Kit according to the
manufacturer’s instructions (Santa Cruz Biotechnology, Inc.). In
brief, NSCs were washed with the Assay Buffer and incubated with
the solution of Annexin V (10 mg/ml, FITC conjugated),
propidium iodide (PI, 1 mg/ml) and Hoechst33342 (1 mM) in the
dark at room temperature for 15 min. Cells were mounted in the
Assay Buffer and photographed with a Leica epifluorescence
microscope. Normal viable cells were stained negative for both
FITC conjugated Annexin V and PI while FITC-Annexin V
bound to early apoptotic cells, which were not stained by PI. Cells
at late stages of apoptosis and necrotic cells were stained positive
for Annexin V FITC and PI. The percentages of apoptotic and
necrotic cells were determined by counting the numbers of cells
with Annexin V positive but PI negative (early-to-intermediate
stages of apoptosis), cells with PI positive plus chromatin
condensation (late apoptosis), and cells with PI positive but
without chromatin condensation (necrosis). The total number of
cells were counterstained with Hoechst33342.
Caspase-3 Immunofluorescence Staining
Caspase-3, one of the key enzymes of apoptosis, was immuno-
fluorescently detected with the rabbit anti-cleaved caspase-3
(Asp
175) pAb (Calbiochem) as the primary antibody. After various
drug treatments, NSCs were fixed with 4% PFA, rinsed in PBS,
incubated in 10% (v/v) goat normal serum to block non-specific
binding sites, and then incubated with the primary antibody
(1:1000) at 4uC overnight. After washes in PBS, the cells were
incubated with Cy3-conjugated anti-rabbit IgG (1:400, Jackson
Immunological Research, PA, USA) at room temperature for
30 min, rinsed in PBS, then counterstained with nuclear
fluorescent stain Hoechst33342 and mounted with glycerin PBS.
Negative control was performed by omitting the primary antibody.
Positive cells were counted under a Leica epifluorescence
microscope, and their percentage was calculated.
Detection of Intracellular ROS Using Carboxy-H2DCFDA
The Image-iT
TM LIVE Green Reactive Oxygen Species (ROS)
Detection Kit (Molecular Probes, Invitrogen Inc.) was used to
assess intracellular ROS levels in NSCs. The assay is based on the
reaction of ROS with the hydrolytic products of 5-(and-6)-
carboxy-29,7 9-dichlorodihydrofluorescein diacetate (carboxy-
H2DCFDA), a reliable fluorogenic marker for ROS in live cells
[79]. After diffusing into the cells, carboxy-H2DCFDA is
hydrolyzed to the polar non-fluorescent form (carboxy-DCFH)
and trapped within cells. The carboxy-DCFH is further oxidized
by ROS to a fluorescent dichlorofluorescein (carboxy-DCF). After
various drug treatments, ROS levels within NSCs were detected
by following the manufacturer’s instructions of the detection kit
(Molecular Probes, Invitrogen Inc.). The cells were examined
under a Leica epifluorescence microscope with the excitation
source and filter for fluorescein FITC. For quantification, the cells
were examined with a fluorescent plate reader (TECAN, Genios)
at excitation and emission wavelengths of 485 and 535 nm,
respectively. The relative fluorescent unit (RFU) of each sample
was calculated (Table 1).
BrdU Labeling
NSCs were treated with BrdU (10 mM) three times (each for
4 hr) from the time when STZ was administered. BrdU labeling
was performed with BrdU/DAPI immunofluorescent double
labeling method [80,81]. After NSCs were fixed with 4% PFA,
nuclei were first stained with the DNA-marker DAPI (50 mg/ml) at
37uC for 20 min, and then the DNA of cells was denatured by
incubation in 2 N HCl at 37uC for 30 min. Non-specific
immunoreactions were blocked with 10% normal goat serum.
The mouse monoclonal anti-BrdU antibody (Sigma Chemical Co.,
St. Louis, USA; 1:400) was used as the primary antibody, and
Cy3-conjugated anti-mouse IgG (Jackson Immunological Re-
search; 1:400) as the secondary antibody. The staining procedure
was the same as the caspase-3 staining described above. Negative
control was performed by using NSCs without receiving any BrdU
treatments. Fluorescent signals were detected under a Leica
epifluorescence microscope. BrdU positive cells were counted and
compared to the total number of cells as determined by DAPI
nuclear staining.
Detection for Neuronal Differentiation of NSCs
Experimental grouping was the same as above, but the
treatment procedure was slightly modified for the detection of
neuronal differentiation of NSCs. Neurospheres at P2 were plated
on poly-L-lysine-coated coverslips and grown in the differentiation
culture medium for seven days. The concentrations of various
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STZ or H2O2 was changed to 1 h per day for 7 consecutive days.
Every day, the culture medium was refreshed after STZ/H2O2
treatment. The cells were pretreated with salidroside or catalase
for 4 hr before each STZ treatment. After various treatments,
immunofluorescence localization of neuronal markers, namely
MAP2, NF150 and Tuj1, was performed using mouse monoclonal
anti-MAP2 (Sigma Chemical Co., St. Louis, USA; 1:300), rabbit
polyclonal anti-NF150 (Sigma Chemical Co., St. Louis, USA;
1:200) and rabbit polyclonal anti-bIII tubulin (Sigma Chemical
Co., St. Louis, USA; 1:60) primary antibodies, respectively, and
FITC- (1:100) and Cy3-conjugated (1:400) secondary antibodies
(Jackson Immunological Research). Negative controls were
performed by omitting the primary antibodies.
Cell Counts and Statistical Analyses
After immunostaining, fluorescent signals were examined under
a Leica epifluorescence microscope. For quantification of
neurogenesis in vivo, six coronal sections through the dorsal
hippocampus (anterio-posterior extent from 15.86 to 12.96 mm)
from each animal were analyzed for BrdU-positive cells in the
granular cell layer (GCL) and the subgranular zone (SGZ) of the
dentate gyrus (DG). The SGZ was defined as the cellular layer of
two-nuclei wide below the border between the GCL proper and
the hilus [82,83]. All BrdU positive nuclei in these selected areas
were counted and the percentages of BrdU
+Tuj1
+ double positive
cells among all BrdU positive cells were calculated. For
quantification of immunoreactive cells in vitro, cells in each culture
were counted with a 206objective. Five visual fields were selected
from the upper left, upper right, lower left and lower right corners
and also the central part of the culture with a total of 25 visual
fields. Data collected for each culture included the total number of
cells (based on Hoechst33342 or DAPI staining) and numbers and
percentages of cells immunoreactive to individual antibodies.
Statistical Analyses
Data analyses were performed with one-way ANOVA, followed
by post hoc comparison with the S-N-K post hoc test using SPSS
software (Version 12.0, SPSS Inc., Chicago, IL, USA). Data were
presented as mean6SD. Significance levels were set to 0.05 for all
comparisons.
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